Pangea's Amino forms collab with U of A scientists

Mr. Pratap Sandhu reports AMINO INNOVATIONS FORMS STRATEGIC RESEARCH PARTNERSHIP WITH UNIVERSITY OF ALBERTA SCIENTISTS TO ADVANCE PEPTIDE INNOVATION Pangea Natural Foods Inc.'s wholly owned subsidiary, Amino Innovations, has formed a strategic scientific collaboration partnership with two world-renowned pharmaceutical scientists, Dr. Neal Davies and Dr. Raimar Loebenberg, to accelerate the research, validation and development of advanced non-injectable peptide delivery systems for consumer wellness applications. Dr. Davies and Dr. Loebenberg, both senior professors in the faculty of pharmacy and pharmaceutical sciences at the University of Alberta, will provide formulation and validation expertise through a research services agreement that leverages access to the University's Drug Development and Innovation Centre (DDIC) and its state-of-the-art facilities, personnel and pharmaceutical testing platforms. Scope of collaboration Through this collaboration, Amino Innovations aims to establish a new benchmark for precision peptide delivery across oral, dermal and topical formulations. The team will conduct in vitro, ex vivo and in silico studies to quantify absorption, bioavailability and stability of select peptides, including BPC-157, GHK-Cu, and KPV, using natural and safe permeation enhancers such as Tremella fuciformis (Snow Mushroom) and DMSO to improve efficacy and product performance. Key areas of research include: Pharmacokinetic (PK) and pharmacodynamic (PD) modelling to optimize formulation parameters and delivery profiles; Permeation and dissolution testing using skin and tissue-based membrane models; Formulation refinement using natural excipients and botanical actives for enhanced bioavailability; Stability and analytical testing to confirm product integrity and longevity. The data generated from this research will strengthen Amino Innovations' growing intellectual property portfolio, enhance regulatory credibility and accelerate new product development across the nutraceutical and cosmeceutical markets. Dr. Neal Davies and Dr. Raimar Loebenberg stated: "We are thrilled to work with Amino Innovations, a company that is focused on evidence-based, non-injectable natural peptide innovation. Our expertise in biopharmaceutics, formulation science and translational research will help bring forward validated peptide technologies with measurable impact in wellness and health science." Justin Kirkland, chief scientific officer and co-founder of Amino Innovations, commented: "This partnership gives us access to leading research expertise and infrastructure. By generating pharmacokinetic and permeability data on key peptide actives, we are creating a level of scientific transparency within the wellness industry." Pratap Sandhu, chief executive officer of Pangea, added: "We are excited to support Amino Innovations as it continues to lead in science driven wellness innovation. This partnership reinforces our commitment to developing credible, research-backed products that strengthen scientific integrity and drive long-term growth." About Pangea Natural Foods Inc. Pangea Natural Foods is a North American manufacturer specializing in clean-label foods and innovative wellness products. Through its subsidiary, Amino Innovations, the company offers advanced, non-injectable peptide delivery systems that support recovery, cognitive function and overall health. We seek Safe Harbor.